Pfizer
Kelley Olree, MS, has extensive experience in clinical research and operations, most notably as Clinical Study Team Lead and Director at Pfizer since July 2015. Previous roles include Senior Manager and Compliance Oversight Lead at Pfizer, as well as Lead CRA at Theorem Clinical Research, where Kelley managed clinical operations for a pivotal phase 3 women’s health trial. Additionally, Kelley's experience spans positions at Novo Nordisk A/S, Kforce, Clinimetrics, Sanofi, Research Solutions, and UAMS/CAVHS, covering various aspects of clinical research coordination and management. Kelley holds a Master of Science in Nutrition from Texas Woman's University and a Bachelor of Science in Clinical Dietetics from UT Southwestern Medical Center, along with other relevant degrees.
This person is not in any teams
This person is not in any offices
Pfizer
614 followers
Pfizer Inc. is a research-based, global biopharmaceutical company. They apply science and their global resources to bring therapies to people that extend and significantly improve their lives through the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. They work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Pfizer collaborates with healthcare providers, governments and local communities to support and expand access to reliable, affordable healthcare around the world. Pfizer was founded in 1942. Most of Pfizer’s revenues come from the manufacture and sale of biopharmaceutical products. They believe that their medicines and vaccines provide significant value for healthcare providers and patients, through improved treatment of diseases, improvements in health, wellness and productivity as well as by reducing other healthcare costs, such as emergency room or hospitalization. Pfizer is committed to fulfilling their purpose: Breakthroughs that change patients’ lives. Their purpose fuels everything they do and reflects both their passion for science and commitment to patients. Pfizer’s growth strategy is driven by five “Bold Moves” that help them deliver breakthroughs for patients and create value for shareholders and other stakeholders: 1. Unleash the power of our people; 2. Deliver first-in-class science; 3. Transform our go-to-market model; 4. Win the digital race in pharma; and 5. Lead the conversation.